SUNY Downstate College of Medicine

Jordan C. Collier, MD, is recognized by Continental Who's Who

Retrieved on: 
Monday, August 29, 2022
Memorial, Chronic lung disease, Degenerative disease, Obesity, Continental, Oakwood University, American Board of Commissioners for Foreign Missions, Internal medicine, Indian Medical Association, SUNY Downstate College of Medicine, SUNY, State university system, Medicine, American Board of Internal Medicine, American Medical Association, Hospital medicine, State, Teaching hospital, Northern Westchester Hospital, Medical degree, University Hospital of Brooklyn at Long Island College Hospital, Hospital, Multimedia, SUNY Downstate Medical Center, MD, International Weightlifting Federation, Family, Adult, Diabetes, Basketball, Jordan, Bachelor of Science, Patient, Medical device, Health insurance

NEW ROCHELLE, N.Y., Aug. 29, 2022 /PRNewswire/ -- Jordan C. Collier, MD, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional in the Medical field and in acknowledgment of his exemplary work with CareMount Medical.

Key Points: 
  • NEW ROCHELLE, N.Y., Aug. 29, 2022 /PRNewswire/ -- Jordan C. Collier, MD, is being recognized by Continental Who's Who as a Distinguished Healthcare Professional in the Medical field and in acknowledgment of his exemplary work with CareMount Medical.
  • A board-certified internist with over 13 years of medical experience, Dr. Jordan Collier is in practice with CareMount Medical, which serves patients throughout Westchester County and the surrounding region.
  • A specialist in hospital medicine, Dr. Collier is affiliated with Northern Westchester Hospital in Mt.
  • In pursuit of his medical career, Dr. Collier obtained his Bachelor of Science degree from Oakwood University in 2003.

Dr. Sergey Motov at Maimonides Medical Center to Host Webinar on using MeMed BV® in the Emergency Department to rapidly differentiate bacterial and viral infections

Retrieved on: 
Wednesday, July 13, 2022
Emergency, Hospital, SUNY Downstate College of Medicine, Maimonides, Solution, IDT, Maimonides Medical Center, Patient, Emergency department, Physician, Education, Northwell Health, Internet meme, Yale Cancer Center, Medical Center, Department, Research, Serum, Emergency medicine, Vaccine

From research to clinical use of MeMed BV in the Emergency Department where he will share how he and his team use the MeMed BV test in the Emergency Department to rapidly differentiate between bacterial and viral infections.

Key Points: 
  • From research to clinical use of MeMed BV in the Emergency Department where he will share how he and his team use the MeMed BV test in the Emergency Department to rapidly differentiate between bacterial and viral infections.
  • The webinar will take place on July 21, 2022 at 1:00 pm EDT/ 7:00 pm CET/ 8:00 pm IDT.
  • Dr. Motov will describe MeMed BV, a first-of-its kind test that decodes the immune response and accurately differentiates between bacterial or viral infections in 15 minutes from serum.
  • Dr. Motov will also discuss patient selection, clinical implementation, and the initial impact of using MeMed BV in his Emergency Department.

Maimonides Medical Center Adopts Revolutionary Technology That Quickly Distinguishes Bacterial and Viral Infections

Retrieved on: 
Tuesday, March 22, 2022
Adoption, Maimonides Medical Center, Degenerative disease, Diagnosis, Emergency medicine, Medical Center, Maimonides, Inflammation, Yale Cancer Center, Education, Research, Hospital, Medicine, Internet meme, National action plan, Immune system, Northwell Health, Technology, Goal, Physician, Infection, SUNY Downstate College of Medicine, Department, FDA, Patient, Pharmaceutical industry, Medical imaging

(Brooklyn, NY) Today, Maimonides Medical Center announced a landmark agreement with MeMed, an Israel-based medical technology firm, for the adoption of MeMed BV, a new, FDA-approved, cutting-edge test that distinguishes whether a patient is suffering from a bacterial or viral infection within 15 minutes.

Key Points: 
  • (Brooklyn, NY) Today, Maimonides Medical Center announced a landmark agreement with MeMed, an Israel-based medical technology firm, for the adoption of MeMed BV, a new, FDA-approved, cutting-edge test that distinguishes whether a patient is suffering from a bacterial or viral infection within 15 minutes.
  • At Maimonides, were committed to clinical excellence and advancing innovative approaches in order to improve patient outcomes for Brooklynites and beyond.
  • Founded in 1911, the Medical Center continues to grow and adapt to the needs of Brooklyns patients and families.
  • For additional information on the nationally recognized clinical services at Maimonides Medical Center, please visit www.maimo.org .

Otsuka Medical Devices’ REQUIRE Trial Results Presented at Japan Society of Hypertension Annual Meeting

Retrieved on: 
Friday, October 15, 2021
Biotechnology, Health, Clinical Trials, Medical Devices, Tokyo Stock Exchange, CE, JSH, PMA, Synthetic control method, Mortality, Society, Disease, Medical device, SUNY Downstate College of Medicine, FDA, Patient, TRIO, List of Nature Research journals, CEO, Blood pressure, OMD, Safety, CA, Pharmaceutical industry, ReCor Medical, Inc., Otsuka Medical Devices Co., Ltd., RECOR MEDICAL, INC., OTSUKA MEDICAL DEVICES CO., LTD.

Otsuka Medical Devices Co., Ltd. (OMD) a subsidiary of Otsuka Holdings, Inc., and its subsidiary, ReCor Medical, Inc. (ReCor), today announced that the findings from the REQUIRE trial of ReCors Paradise Ultrasound Renal Denervation System for the treatment of hypertension conducted in Japan and Korea were presented at the Japanese Society of Hypertension (JSH) meeting and published simultaneously in the Hypertension Research journal.

Key Points: 
  • Otsuka Medical Devices Co., Ltd. (OMD) a subsidiary of Otsuka Holdings, Inc., and its subsidiary, ReCor Medical, Inc. (ReCor), today announced that the findings from the REQUIRE trial of ReCors Paradise Ultrasound Renal Denervation System for the treatment of hypertension conducted in Japan and Korea were presented at the Japanese Society of Hypertension (JSH) meeting and published simultaneously in the Hypertension Research journal.
  • The trial, Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial, was conducted by OMD and its affiliate.
  • ReCor Medical is a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd.
    About Otsuka Medical Devices Co., Ltd.
    Otsuka Medical Devices focuses on the global development and commercialization of endovascular devices that provide new therapeutic options in areas where patient needs cannot be met through pharmaceutical or other conventional treatment.
  • Otsuka Medical Devices Co., Ltd. is a subsidiary of Otsuka Holdings Co., Ltd. ( www.otsuka.com/en ), a leading global healthcare group listed on the Tokyo Stock Exchange (JP 4578).

MedCraft Healthcare Real Estate Completes the 150,000 Square Foot Maimonides Doctors Multispecialty Pavilion

Retrieved on: 
Wednesday, October 6, 2021
Commercial Building & Real Estate, Construction & Property, Practice Management, Health, Building Systems, Hospitals, REIT, Interior Design, Hospital Insurance and Diagnostic Services Act, Northwell Health, MD Anderson Cancer Center, Education, Patient, Hospital, Multimedia, Stephen Colbert's AmeriCone Dream, Physician, SUNY Downstate College of Medicine, Maimonides Medical Center, Nursing, Federation, CEO, LLC, 49th Street station (BMT Broadway Line), Ninth Avenue, Research, Ambulatory care, Medical Center, Medicine, MedCraft Healthcare Real Estate, LLC, Maimonides Medical Center, MEDCRAFT HEALTHCARE REAL ESTATE, LLC, MAIMONIDES MEDICAL CENTER

MedCraft is one of the most active national healthcare real estate firms on the East Coast with a focus on development, acquisitions and real estate advisory with several leading providers and health systems.

Key Points: 
  • MedCraft is one of the most active national healthcare real estate firms on the East Coast with a focus on development, acquisitions and real estate advisory with several leading providers and health systems.
  • View the full release here: https://www.businesswire.com/news/home/20211006005752/en/
    MedCraft Healthcare Real Estate Principal Keith Beneke joins Maimonides President & CEO Kenneth Gibbs and a team of distinguished executives and departmental leaders to cut the ceremonial ribbon at the grand opening of the Maimonides Doctors Multispecialty Pavilion.
  • Maimonides Doctors Pavilion, the new flagship center of Maimonides system of care, represents a major milestone in the continued transformation of Maimonides to better serve patients.
  • About MedCraft Healthcare Real Estate, LLC
    MedCraft Healthcare Real Estate is a full-service healthcare real estate firm that specializes in advisory, development, and financing services to health systems and physicians.

Urovant Sciences to Present New Ambulatory Blood Pressure Data in Patients Dosed With GEMTESA® (vibegron) 75 mg for Overactive Bladder at the Virtual 2021 Annual Meeting of the American Urological Association

Retrieved on: 
Friday, September 3, 2021
Biotechnology, Pharmaceutical, Health, Clinical Trials, Allergy, Urology, Female, Vitamin, The Journal of Urology, Sumitomo Dainippon Pharma, Nausea, SUNY Downstate College of Medicine, Sore throat, PDT, Adult, Abstract (summary), European Union, Consideration of future consequences, Man, Clinical trial, FACS, Overactive bladder, Regulation of tobacco by the U.S. Food and Drug Administration, Diarrhea, Urinary retention, Kidney, Safety, Urinary tract infection, VideoRay UROVs, Center, NYSE, Faculty, Journal, Union, News, State university system, Headache, OAB, MMHC, Urinary incontinence, Digoxin, Liver, Tufts University School of Medicine, American Urological Association, Urologic disease, Breast milk, Doctor of Philosophy, FDA, Nasal congestion, Upper respiratory tract infection, State, Food, EVP, Pharmaceutical industry, Dietary supplement, Fine chemical, GEMTESA®, Urovant Sciences, GEMTESA®, UROVANT SCIENCES

The AUA21 virtual podium presentation will examine new clinical trial data on the effect of GEMTESA on ambulatory blood pressure in OAB patients.

Key Points: 
  • The AUA21 virtual podium presentation will examine new clinical trial data on the effect of GEMTESA on ambulatory blood pressure in OAB patients.
  • A separate virtual poster presentation will demonstrate its efficacy in patients with dry overactive bladder (without urinary leakage), based on a post-hoc analysis of data from the pivotal EMPOWUR study.
  • We believe that GEMTESA can help meet the needs of the estimated 30 million Americans who suffer from the bothersome symptoms of this condition.
  • This podium presentation will take place on Monday, September 13, during a virtual session from 1:00 to 3:00 p.m. PDT.

The New York Academy Of Medicine Welcomes New Board Chair Dr. Wayne Riley, President Of SUNY Downstate

Retrieved on: 
Wednesday, October 21, 2020
East Flatbush, Brooklyn, SUNY Downstate Medical Center, V-12 Navy College Training Program, Downstate, State University of New York, Nyam, New York City, New York state), SUNY Downstate College of Medicine

New York, NY, Oct. 21, 2020 (GLOBE NEWSWIRE) -- The New York Academy of Medicine (NYAM) and SUNY Downstate Health Sciences University jointly announcedWayne J. Riley, MD, MPH, MBA, MACP, as Chair of NYAMs Board of Trustees.

Key Points: 
  • New York, NY, Oct. 21, 2020 (GLOBE NEWSWIRE) -- The New York Academy of Medicine (NYAM) and SUNY Downstate Health Sciences University jointly announcedWayne J. Riley, MD, MPH, MBA, MACP, as Chair of NYAMs Board of Trustees.
  • Dr. Riley is the 17thpresident of the Brooklyn-based SUNY Downstate Health Sciences University, where he also holds tenured professorships in internal medicine, health policy, and management.
  • I am honored to assume the role of Chairman of the Board of The New York Academy of Medicine, saidDr.
  • Gina Ravosa The New York Academy of Medicine 212.822.7285 [email protected] Dawn S. Walker SUNY Downstate 917.439.9666 [email protected]

OCLI Welcomes Board-Certified Ophthalmologist Christopher R. Adam, MD Specialist in retinal and vitreous diseases

Retrieved on: 
Thursday, August 20, 2020
Geography of New York state), New York state), Setauket-East Setauket, New York, SUNY Downstate Medical Center, Stony Brook University, State University of New York, SUNY Downstate College of Medicine, Stony Brook station, Setauket station, Brooklyn

Beginning on August 10, 2020, he will see patients at OCLI's Patchogue, Port Jefferson and East Setauket offices.

Key Points: 
  • Beginning on August 10, 2020, he will see patients at OCLI's Patchogue, Port Jefferson and East Setauket offices.
  • Dr. Adam earned his medical degree from SUNY Downstate College of Medicine after receiving a BA from SUNY Stony Brook University.
  • "I'm very excited about joining OCLI, which is well known for its unwavering commitment to delivering the most advanced eye care," says Dr. Adam.
  • His deep knowledge of retinal and vitreous diseases will greatly expand patients' eye care options and further strengthen OCLI's reputation in the areas it serves."